United Kingdom

Market Access

The Windsor Framework: Insights on the regulatory shift for ...

The Windsor Framework marks a significant change in the UK's post-Brexit regulatory space, particularly for the pharmaceutical sector

Market Access

Progress with the UK’s VPAG

Leela Barham looks at the first operational review meeting minutes that have been published on the VPAG, the UK’s latest scheme on branded medicines pricing and access, building on previous

Market Access

Metrics for the UK’s VPAG: A work in progress

Just as for previous schemes, metrics are being used to track VPAG, the UK’s voluntary scheme that covers branded medicines pricing and access.

News

Research shows NHS, industry partnership benefits patients

A new report commissioned by the Association of the British Pharmaceutical Industry (ABPI) has found that hospitals engaging in industry partnerships are up to 2.5 times more likely to foll

The Windsor Framework: Insights on the regulatory shift for ...

Progress with the UK’s VPAG

Metrics for the UK’s VPAG: A work in progress

Research shows NHS, industry partnership benefits patients

FDA approves higher Wegovy dose via 4th priority voucher

Using AI-driven synthetic personas to take your insights fur...

United Kingdom

Editor's Picks